日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pregnancy Outcomes After Maternal or Paternal Exposure to Tofacitinib Across Clinical Programs

临床项目中,母亲或父亲接触托法替尼后的妊娠结局

Mahadevan, Uma; Chaparro, María; Segovia, Michelle; Guo, Xiang; Kulisek, Nicole; Wu, Joseph; Vranic, Ivana; Diehl, Annette; Kavanaugh, Arthur; Dubinsky, Marla

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的中度活动性溃疡性结肠炎患者有效

Yarur, Andres; Irving, Peter; Siegmund, Britta; Dubinsky, Marla C; Ananthakrishnan, Ashwin N; Regueiro, Miguel; Ungaro, Ryan C; Ritter, Timothy; Nakase, Hiroshi; Liu, Zhaohui; Mehra, Dimpy; Osterman, Mark T; Jain, Anjali; Rubin, David T; Hibi, Toshifumi

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn's disease: rationale, design and protocol for the randomised controlled VECTORS trial

评估以全层愈合为目标治疗中重度活动性克罗恩病患者的疗效:随机对照 VECTORS 试验的原理、设计和方案

Jairath, Vipul; Vuyyuru, Sudheer K; Zou, Guangyong; Ma, Christopher; Neustifter, Blue; Agboton, Christian; Romo Bautista, Itzel; Allocca, Mariangela; An, Yoon-Kyo; Begun, Jakob; Bryant, Robert V; Danese, Silvio; Dubinsky, Marla; Feagan, Brian G; Freire, Marcelo; Novak, Kerri L; Panaccione, Remo; Pudipeddi, Aviv; Rubin, David T; Sands, Bruce E; Sparrow, Miles P; Taylor, Stuart A; Gecse, Krisztina B; Wilkens, Rune; Maaser, Christian

Reshaping study design for faster extrapolation-based drug approval in pediatric inflammatory bowel diseases: An ESPGHAN-NASPGHAN position paper

重塑研究设计以加快基于外推法的儿科炎症性肠病药物审批:ESPGHAN-NASPGHAN 立场文件

Turner, Dan; Assa, Amit; Malham, Mikkel; Bar-Asher, Shira Yuval; Rayan, Carla; Hyams, Jeffrey S; Uhlig, Holm H; Pasternak, Brad; Wilson, David C; Michel, Hilary K; de Ridder, Lissy; Zuckerman, Eric; Aloi, Marina; Szitanyi, Peter; Dubinsky, Marla C; Griffiths, Anne M; Saldana, Roberto; Martín-de-Carpi, Javier; Wine, Eytan; Russell, Richard K; Adler, Jeremy; Picoraro, Joseph

Ultrasound cystic artery velocity as a predictor for acute cholecystitis in patients presenting to the emergency department

超声胆囊动脉血流速度作为急诊科就诊患者急性胆囊炎的预测指标

Srivastava, Saubhagya; Dhyani, Manish; Dighe, Manjiri; Kumar, Tushar; Fetzer, David T; Cunha, Guilherme M; Dubinsky, Theodore J

Gut microbiota strain richness is species specific and affects engraftment

肠道菌群菌株丰富度具有物种特异性,并影响移植成功率。

Chen-Liaw, Alice; Aggarwala, Varun; Mogno, Ilaria; Haifer, Craig; Li, Zhihua; Eggers, Joseph; Helmus, Drew; Hart, Amy; Wehkamp, Jan; Lamousé-Smith, Esi S N; Kerby, Robert L; Rey, Federico E; Colombel, Jean Frédéric; Kamm, Michael A; Olle, Bernat; Norman, Jason M; Menon, Rajita; Watson, Andrea R; Crossette, Emily; Terveer, Elisabeth M; Keller, Josbert J; Borody, Thomas J; Grinspan, Ari; Paramsothy, Sudarshan; Kaakoush, Nadeem O; Dubinsky, Marla C; Faith, Jeremiah J

An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease

关于炎症性肠病临床试验中皮质类固醇合理使用的国际共识

Hanžel, Jurij; Solitano, Virginia; Vuyyuru, Sudheer Kumar; Panaccione, Remo; Sands, Bruce E; Peyrin-Biroulet, Laurent; Danese, Silvio; D'Haens, Geert R; Atreya, Raja; Allez, Matthieu; Bernstein, Charles N; Bossuyt, Peter; Bressler, Brian; Bryant, Robert V; Cohen, Benjamin L; Colombel, Jean-Frederic; D'Amico, Ferdinando; Dignass, Axel; Dubinsky, Marla; Fleshner, Phillip; Gearry, Richard B; Hanauer, Stephen B; Hart, Ailsa L; Kayal, Maia; Kucharzik, Torsten; Lakatos, Peter L; Louis, Edouard; Magro, Fernando; Narula, Neeraj; Leong, Rupert W; Panés, Julián; Raine, Tim; Ran, Zhihua; Regueiro, Miguel D; Reinisch, Walter; Singh, Siddharth; Steinhart, A Hillary; Travis, Simon; Ungaro, Ryan C; van der Woude, C Janneke; Yamamoto, Takayuki; Ahuja, Vineet; Rubin, David T; Dulai, Parambir S; Cornfield, Linda J; Hogan, Malcolm; Sandborn, William J; Feagan, Brian G; Jairath, Vipul; Ma, Christopher

Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies

基于既往对高级疗法反应不足或不耐受的Risankizumab疗效和安全性:INSPIRE和COMMAND 3期研究的事后分析

Panaccione, Remo; Louis, Edouard; Colombel, Jean-Frederic; D'Haens, Geert; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Takeuchi, Ken; Rubin, David T; Kalabic, Jasmina; Chien, Karen B; Chen, Su; Cheng, Ling; Zhang, Yafei; Duan, W Rachel; Vladea, Ramona; Hecht, Patrick M; Morisset, Pierre; Schreiber, Stefan; Ferrante, Marc

Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel disease

炎症性肠病中代谢途径的显著紊乱与疾病进展相关

Bourgonje, Arno R; Ibing, Susanne; Livanos, Alexandra E; Ganjian, Danielle Y; Argmann, Carmen; Sands, Bruce E; Dubinsky, Marla C; Helmus, Drew S; Jacobsen, Henrik A; Larsen, Lone; Jess, Tine; Suarez-Fariñas, Mayte; Renard, Bernhard Y; Colombel, Jean-Frédéric; Ungaro, Ryan C

Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b study

奥贝法齐莫德治疗中重度活动性溃疡性结肠炎患者的疗效和安全性分析:一项为期 96 周的开放标签维持期 2b 研究

Vermeire, Severine; Nitcheu, Josianne; Gineste, Paul; Flatres, Aurélien; Santo, Julien; Scherrer, Didier; Peyrin-Biroulet, Laurent; Dulai, Parambir S; Danese, Silvio; Dubinsky, Marla; Tilg, Herbert; Siegmund, Britta; Hisamatsu, Tadakazu; Shan, Kejia; Rabbat, Christopher J; Sands, Bruce E